Daily Dose - Dec 12th, 2024
Daily Dose |
View online
December 12, 2024
Key drugs losing patent protection in 2025
From life-saving diabetes medications to essential respiratory treatments, several high-profile drugs will lose their patent exclusivity next year, representing billions of dollars in sales and years of therapeutic innovation.
Read More
Lonza to exit capsules and health ingredients business, focus on CDMO services
The Swiss-based contract development and manufacturing organization wants to become a “pure-play” CDMO business.
Read More
Vertex, Saudi Arabia to collaborate on gene therapy manufacturing
The agreement aims to enhance R&D, biomanufacturing, and training Saudi talent in biotechnology.
Read More